SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023  

May 9 2023
Strong growth momentum and efficient expense execution continues BOSTON and LAUSANNE, Switzerland, May 09, 2023 (GLOBE NEWSWIRE) --  SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the first quarter ended March 31,

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Junior Information Security Analyst Intern France Regulatory & Quality
Sales Executive / Senior Sales Executive United Kingdom Clinical Sales
Strategic Account Manager - JAPAN Japan Clinical Sales
BioPharma Business Development Expert / Manager Switzerland BioPharma Sales
Junior Sales Operations Specialist Intern France Clinical Sales